Overall Technical outlook

Price Summary

On 2026-04-09, Piramal Pharma Limited's shares started at 143.77, peaked at 145.78, bottomed out at 142.11, and ended -0.57% down at 142.95, with 1581620 shares traded.
The stock's highest price in the past 52 weeks is 224.46, while its lowest price during the same period is 0.0.
According to 10 analysts, the price of PPLPHARMA in the future is projected to be between 195.0 and 310.0, with an average expected price of 234.9.

Technicals

Support and Resistance: At 142.95, the price is supported at 0.0 and faces resistance at 153.69. This range suggests that the price for PPLPHARMA might stay between these levels, with 0.0 acting as a floor and 153.69 as a ceiling.
PPLPHARMA supportResistance da88fd
Support/Resistance for PPLPHARMA


Aroon: The AROON is currently in a neutral position for Piramal Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
PPLPHARMA aroon da88fd
Aroon chart for Piramal Pharma Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
PPLPHARMA bbands da88fd
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR for PPLPHARMA continues to be bullish, establishing a crucial support level that may help maintain the current upward trend. This level of support suggests that the market is poised to continue its positive trajectory, offering a foundation for further growth.
PPLPHARMA psar da88fd
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
PPLPHARMA stoch da88fd
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods indicate a bullish trend, though the slopes of the faster averages suggest that this trend may not last. The weakening signals from the shorter-term averages point to a potential reversal, indicating that the current upward momentum could be approaching a turning point.
PPLPHARMA trippleSMA da88fd
Tripple SMA chart for Piramal Pharma Limited


To accurately interpret a company's technical data, it is important to first examine its fundamentals. These include financial performance, management quality, and growth prospects. In addition, understanding the dynamics of the industry in which the company operates—such as competition, market trends, and regulatory factors—provides further insights. This combined analysis helps create a fuller picture, allowing for more precise conclusions to be drawn from the company's technical performance and stock behavior.